Clinical trial
An Evaluation of the AttenueX IntraVesical System in the Management of Female Subjects With Stress Urinary Incontinence
NCT00492596 is registered in ClinicalTrials.gov with Solace Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Evaluation of the AttenueX IntraVesical System in the Management of Female Subjects With Stress Urinary Incontinence
- Lead sponsor
- Solace Therapeutics, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 30, 2006
- Completion date
- June 30, 2011
- Enrollment
- 166 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.